Semaglutide

Semaglutide is a lab-made version of GLP-1, a hormone your gut releases after you eat. It sends the same 'I'm full' and blood-sugar-balancing signals your body uses naturally.

It draws attention because approved medicines using semaglutide (like Wegovy and Ozempic) help with weight management and blood-sugar control. Researchers study how those signals travel between the gut and the brain.

Large clinical trials in approved drugs showed real, measurable weight loss and improved blood-sugar control. Those benefits are established in the medicines — the underlying biology is still being mapped.

Distinguishes established clinical findings from early human trials, animal experiments, or laboratory cell culture findings. No human dosing, injection instructions, or treatment recommendations are provided.

Semaglutide is the active ingredient in several FDA-approved prescription medicines. BBOHC's material is a research reference reagent, not an approved drug.

BBOHC LABS research reagents are non-clinical materials. An FDA approval for a finished medicine containing the same active ingredient does not imply that BBOHC's investigational research vial is FDA-approved.

Slows stomach emptying and can affect appetite signaling in animal studies. Handle with standard laboratory PPE.

• Drucker DJ. Mechanisms of Action and Therapeutic Application of GLP-1. Cell Metab. 2018.
• FDA Prescribing Information: Wegovy (semaglutide) injection.

Specific citations are provided for literature context. Product purity & lot verification documentation available on request.